The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials

Type 2 Diabetes Mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are part of metabolic syndrome and share multiple causal associations. Both conditions have an alarmingly increasing incidence and lead to multiple complications, which have an impact on a variety of organs and systems, su...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ioana-Cristina Bica, Roxana Adriana Stoica, Teodor Salmen, Andrej Janež, Špela Volčanšek, Djordje Popovic, Emir Muzurovic, Manfredi Rizzo, Anca Pantea Stoian
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-06-01
Serie:	Medicina
Soggetti:	sodium-glucose cotransporter 2-inhibitors steatosis fibrosis non-alcoholic fatty liver disease non-alcoholic steatohepatitis diabetes
Accesso online:	https://www.mdpi.com/1648-9144/59/6/1136
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!